Clinical trial
A Phase I/II Study of Clofarabine in Patients With Relapsed T-Cell and NK-Cell Lymphomas
NCT00416351 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Clofarabine in Patients With Relapsed T-Cell and NK-Cell Lymphomas
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 27, 2006
- Completion date
- March 1, 2021
- Enrollment
- 29 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.